<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR103">
 <label>103.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Livermore</surname>
    <given-names>DM</given-names>
   </name>
   <name>
    <surname>Canton</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Gniadkowski</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Nordmann</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Rossolini</surname>
    <given-names>GM</given-names>
   </name>
   <name>
    <surname>Arlet</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>CTX-M: changing the face of ESBLs in Europe</article-title>
  <source>J Antimicrob Chemother</source>
  <year>2007</year>
  <volume>59</volume>
  <fpage>165</fpage>
  <lpage>174</lpage>
  <?supplied-pmid 17158117?>
  <pub-id pub-id-type="pmid">17158117</pub-id>
 </element-citation>
</ref>
